Prototype antibody discovery

Other Transaction IDV Awarded Last action

Contract number
W911SR2390017
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$18,293,274.00
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Joint PEO Chemical and Biological Defense awarded an Other Transaction IDV to Vanderbilt University Medical Center on August 18, 2023, with a ceiling of $18,293,274 to develop an integrated antibody discovery platform capable of identifying antibodies with high probability of efficacy and developability. This Other Transaction vehicle operates outside the Federal Acquisition Regulation and supports prototype antibody discovery efforts aligned with chemical and biological defense requirements.

Transactions

Action Obligated Date
Funding Only Action P00009 · Develop an integrated antibody discovery platform capable of $767,000
Funding Only Action P00008 $1,583,000
Funding Only Action P00007 $539,241
Funding Only Action P00006 $85,759
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 $375,000
Funding Only Action P00003 $537,214
Funding Only Action P00002 $1,676,000
Funding Only Action P00001 · Develop an integrated antibody discovery platform capable of identifying antibodies (ABS) with a high probability of efficacy and developability. -$2,000,000
Original award $8,000,000

Subawards

Subcontractor Amount Awarded
Vanderbilt University PROTOTYPE ANTIBODY DISCOVERY SBA-Elad Binshtin on Rapid Ecosystem for Agnostic Antibody DiscoverY (REAADY) $25,356
University Of Texas Medical Branch At Galveston DEVELOP AN INTEGRATED ANTIBODY DISCOVERY PLATFORM CAPABLE OF IDENTIFYING ANTIBODIES (ABS) WITH A HIGH PROBABILITY OF EFFICACY AND DEVELOPABILITY. Rapid… $310,000
Vanderbilt University DEVELOP AN INTEGRATED ANTIBODY DISCOVERY PLATFORM CAPABLE OF IDENTIFYING ANTIBODIES (ABS) WITH A HIGH PROBABILITY OF EFFICACY AND DEVELOPABILITY. SBA-Elad… $24,014
Vanderbilt University DEVELOP AN INTEGRATED ANTIBODY DISCOVERY PLATFORM CAPABLE OF IDENTIFYING ANTIBODIES (ABS) WITH A HIGH PROBABILITY OF EFFICACY AND DEVELOPABILITY. SBA-Elad… $28,195
University Of Texas Medical Branch At Galveston PROTOTYPE ANTIBODY DISCOVERY Rapid Ecosystem for Agnostic Antibody DiscoverY (REAADY) $247,634

Quick answers

Who was awarded contract W911SR2390017?

W911SR2390017 was awarded to Vanderbilt University Medical Center by ACC Aberdeen Proving Ground (Army Contracting Command) on August 18, 2023.

How much is contract W911SR2390017 worth?

W911SR2390017's own ceiling is $18,293,274.

Which agency awarded contract W911SR2390017?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2390017, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR2390017 competed?

The extent of competition for W911SR2390017 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login